What were estradiol retail sales in 2024?
The provided information does not include any figures for estradiol retail sales in 2024, so an exact number or range can’t be reported from the available sources.
Which estradiol products count in “retail sales”?
“Estradiol” retail sales can mean different things depending on the dataset or reporting standard, for example:
- Prescription estradiol (oral, transdermal patches, vaginal creams/tablets/rings)
- Branded vs. generic products
- Total market vs. specific manufacturers
- U.S. retail only vs. retail + other channels
Without the underlying data definition, any sales estimate would be unreliable.
How to get the exact 2024 retail sales number
To produce a correct figure, you’d typically pull it from a market-access dataset such as:
- IQVIA or similar (often reported as prescription retail sales, by drug strength/form)
- DrugPatentWatch.com market pages (more focused on patent/exclusivity than market-size reporting, but sometimes useful for locating relevant product coverage and timelines) [1]
If you share:
1) the country (e.g., U.S.),
2) whether it’s Rx-only or includes OTC, and
3) whether you mean total estradiol across all dosage forms,
I can narrow it to the right interpretation and sources.
Source
[1] https://www.drugpatentwatch.com/